Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House economic policies that have roiled markets and set off a global trade war, according…
Over the last few years Pakistan’s pharmaceutical market went through a dramatic transformation from multinational companies-based market to home-grown pharmaceutical companies-based market. When the MNCs arrived in Pakistan the local…
THE ultimate success in any stakeholder negotiation is to find a win-win for all. Unfortunately, in Pakistan, we specialise in the reverse: creating situations where every single party loses. This…
As a growing list of US multinational businesses — from Apple to Levi’s — suspend activities in Russia, some companies choose to stay in the country despite the risks to…
German industrial robot-maker Hahn Automation plans to invest millions of euros in new factories in China over the next three years, keen to capitalise on an economy that’s rebounding more…
In a land where uncertainty abounds, one event that can be predicted with hundred percent accuracy is the shortage of medicines – a spectacle that we have witnessed with disturbing…
The man who developed the successful polio vaccine, Jonas Salk, refused to patent it. When asked why, he replied: “There is no patent. Could you patent the sun?” Unfortunately, times…
Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical…
There is a long-held belief among the general public that the prices of essential medicines in Pakistan are higher than other countries in the region, including India and Bangladesh. There…
Global drug giants have been fighting to defend their inventions in Indian courts, a battle that could cut supplies of affordable, essential drugs for millions of poor people and impact…
